Gen Digital Inc. (GEN), this publicly-traded biotech company continues to be the center of various market reports. Notably, there is an overshadowing conversation on it being undervalued at 29%. It also achieved a new
1-year high at $26.78 and witnessed a
15% surge in its stock which performed robustly against competitors on a strong trading day. Unfortunately, it also
underperformed the market on a few occasions. An insider revealed a reduction in their stake by 51% although the P/E valuation after the 29% spike is still deemed reasonable.
Q1 earnings met estimates and Gen Digital continues to hit headlines even after ex-dividend. Enthusiasts are eyeing the next
earnings report with the Q4 earnings and revenue beating estimates. The balance sheet appears healthy according to Wall Street analysts. A notable mention was the
CFO Natalie Derse selling 169,535 shares of Gen Digital. Furthermore,
CEO Vincent Pilette also sold over $4.5m in company shares. Record earnings were reported in Fiscal 2024. There was a decline in earnings in the past year but investors enjoyed
4.5% growth in the past week. Subsequent fiscal Q1 results will be announced on August 1, 2024.
Gen Digital Stocks GEN News Analytics from Fri, 15 Jul 2016 13:11:14 GMT to Fri, 20 Sep 2024 22:26:40 GMT -
Rating 8
- Innovation 6
- Information 7
- Rumor -6